This study is looking at whether a special type of MRI (magnetic resonance imaging) scan, called T1 Weighted MRI, can help doctors understand how well treatments for myelofibrosis are working. Myelofibrosis is a condition where the bone marrow, which makes blood cells, is scarred. Researchers want to see if changes in these MRI scans can show how much the disease has spread and if treatment is effective. You might be able to join if you are an adult (18-99 years old) with a diagnosis of myelofibrosis and can have an MRI scan without any issues. The goal is to see if these MRI changes can predict treatment response earlier than current methods, with results expected in 5 years. The current status of this study is unclear.

Study design

This is an observational study, meaning researchers will watch and collect information from 192 participants. It is not specified if this study has different phases.

What's involved

You would have an MRI scan at the beginning of the study, again around 6 months (at the time of a scheduled bone marrow biopsy or end of treatment cycle), and a final scan after 12 months.

Compensation

Not stated in the trial record.

Follow-up

The primary goal of this study is to assess treatment response using MRI over 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.